Cargando…
Targeting Multiple-Myeloma-Induced Immune Dysfunction to Improve Immunotherapy Outcomes
Multiple myeloma (MM) is a plasma cell malignancy associated with high levels of monoclonal (M) protein in the blood and/or serum. MM can occur de novo or evolve from benign monoclonal gammopathy of undetermined significance (MGUS). Current translational research into MM focuses on the development o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332181/ https://www.ncbi.nlm.nih.gov/pubmed/22567028 http://dx.doi.org/10.1155/2012/196063 |